These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19119512)

  • 21. Pharmacokinetic interactions between rifabutin and lopinavir/ritonavir in HIV-infected patients with mycobacterial co-infection.
    Khachi H; O'Connell R; Ladenheim D; Orkin C
    J Antimicrob Chemother; 2009 Oct; 64(4):871-3. PubMed ID: 19628472
    [No Abstract]   [Full Text] [Related]  

  • 22. Choice of injectable drugs for retreatment chemotherapy of tuberculosis.
    Moulding T; Davidson PT
    Am Rev Respir Dis; 1977 Sep; 116(3):548. PubMed ID: 900642
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
    Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
    Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacy.
    Yadav AB; Sharma R; Muttil P; Singh AK; Verma RK; Mohan M; Patel SK; Misra A
    Indian J Exp Biol; 2009 Jun; 47(6):469-74. PubMed ID: 19634713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pseudojaundice caused by rifabutine].
    Martínez Rivera C; Andreo García F; Ribas Solà J; Ruiz Manzano J
    Med Clin (Barc); 1997 May; 109(1):38. PubMed ID: 9303980
    [No Abstract]   [Full Text] [Related]  

  • 27. Cycloserine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):100-1. PubMed ID: 18486041
    [No Abstract]   [Full Text] [Related]  

  • 28. Rifalazil.
    Tuberculosis (Edinb); 2008 Mar; 88(2):148-50. PubMed ID: 18486057
    [No Abstract]   [Full Text] [Related]  

  • 29. Rifapentine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):155-8. PubMed ID: 18486059
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains].
    Chikamatsu K; Mizuno K; Yamada H; Mitarai S
    Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rifampicin serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1106-11. PubMed ID: 19723399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Impact of procedures for identifying patients on the pattern of a tuberculous process and the efficiency of treatment].
    Chernov MT
    Probl Tuberk Bolezn Legk; 2008; (11):19-21. PubMed ID: 19143071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibiotic-resistant infectious thoracoabdominal aortic aneurysm; report of a case].
    Shigemoto N; Nakao T; Nakagawa H; Mochizuki S
    Kyobu Geka; 2009 Apr; 62(4):333-5. PubMed ID: 19348220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fighting tuberculosis: old drugs, new formulations.
    Blasi P; Schoubben A; Giovagnoli S; Rossi C; Ricci M
    Expert Opin Drug Deliv; 2009 Sep; 6(9):977-93. PubMed ID: 19678791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Patients with tuberculosis: motivation for treatment].
    Bogorodskaia EM
    Probl Tuberk Bolezn Legk; 2009; (2):3-11. PubMed ID: 19382636
    [No Abstract]   [Full Text] [Related]  

  • 37. [Congenital tuberculosis in preterm neonate: a case report].
    Bonnet C; Michel F; Nicaise C; Chaumoître K; Hassid S; Uters M; Thomachot L; Vialet R; Retornaz K; Lagier P; Martin C
    Arch Pediatr; 2009 May; 16(5):439-43. PubMed ID: 19304463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
    Vishnevskiĭ BI; Steklova LN
    Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality DOTS management and empowering tuberculosis patients.
    Chugh S
    J Indian Med Assoc; 2009 Mar; 107(3):167-8. PubMed ID: 19810385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.